Humacyte, Inc. (HUMA): Price and Financial Metrics
HUMA Price/Volume Stats
| Current price | $4.64 | 52-week high | $9.97 |
| Prev. close | $3.46 | 52-week low | $2.48 |
| Day low | $4.45 | Volume | 75,491,100 |
| Day high | $6.77 | Avg. volume | 2,736,204 |
| 50-day MA | $4.85 | Dividend yield | N/A |
| 200-day MA | $5.43 | Market Cap | 583.99M |
HUMA Stock Price Chart Interactive Chart >
Humacyte, Inc. (HUMA) Company Bio
Humacyte, Inc., a clinical-stage biotechnology platform company, develops and manufactures off-the-shelf bioengineered human tissues. The company develops and manufactures acellular tissues to address life- and limb-threatening vascular conditions for complex organ disease. Its Human Acellular Vessel (HAV), a regenerative vascular conduit that is in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease. The company was founded in 2004 and is based in Durham, North Carolina.
HUMA Price Returns
| 1-mo | 5.94% |
| 3-mo | -10.77% |
| 6-mo | -9.02% |
| 1-year | 61.11% |
| 3-year | -41.04% |
| 5-year | N/A |
| YTD | 63.38% |
| 2023 | 34.60% |
| 2022 | -70.90% |
| 2021 | -28.71% |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...